The Effect and Safety of Recombinant Fibroblast Growth Factor-1 for Carpal Tunnel Syndrome
Clinical trial NCT06328166 · COMPLETED
Trial details
- NCT number
- NCT06328166
- Sponsor
- Tri-Service General Hospital (TSGH)
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-22
- Primary completion
- 2025-05-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.